Neuralstem, Inc. | |||
Statements of Operations | |||
Three Months | |||
Ended March 31, | |||
2011 | 2010 | ||
Revenues | $ - | $ - | |
Operating expenses: | |||
Research and development costs | 1,738,728 | 1,899,963 | |
General and administrative expenses | 1,772,482 | 1,687,835 | |
Depreciation and amortization | 25,293 | 29,063 | |
Total operating expenses | 3,536,503 | 3,616,861 | |
Operating loss | (3,536,503) | (3,616,861) | |
Nonoperating income (expense): | |||
Litigation settlement | 250,000 | - | |
Interest income | 22,892 | 5,811 | |
Interest expense | - | (659) | |
Warrant issuance and modification expense | - | (1,906,800) | |
Gain (loss) from change in fair value adjustment of warrant obligations | 161,809 | (1,248,452) | |
Total nonoperating income (expense) | 434,701 | (3,150,100) | |
Net loss attributable to common shareholders | $ (3,101,802) | $ (6,766,961) | |
Net loss per share - basic and diluted | $ (0.07) | $ (0.18) | |
Weighted average common shares outstanding - basic and diluted | 47,692,878 | 38,539,226 | |
